Clinical trial
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving…
NCT00003139 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003139 |
|---|---|
| Title | Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer |
| Official title | A Phase III Study to Test the Efficacy of the Prophylactic Use of Oral Pilocarpine to Reduce Hyposalivation and Mucositis Associated With Curative Radiation Therapy in Head and Neck Cancer Patients |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Oral Complications |
| Intervention type | Drug, Other |
| Interventions | pilocarpine hydrochloride, Placebo |
| Enrollment | 249 |
| Start date | Mar 1, 1998 |
| Primary completion | Jan 1, 2001 |
| Completion | Oct 1, 2002 |
| First posted | Sep 6, 2004 |
| Last update posted | Nov 17, 2015 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: